Ebola Crisis Causes Drug Claim Symptoms In Products Marketed As Supplements
This article was originally published in The Tan Sheet
FTC joins FDA in one of the three warning letters to firms claiming their products can either prevent or treat Ebola. One firm’s website offers a video titled, “Urgent Message to Ebola-Stricken Nations' Heads of State,” and another claims “primary uses for oregano include athlete’s foot, candida, canker sores, Ebola virus.”
You may also be interested in...
In NAD review on a challenge by S.C. Johnson, which markets Caldrea brand essentials oils, Young Living said because consumers are equally as likely to believe the products are therapeutic grade regardless of which image they saw in a survey demonstrates the claim doesn’t impact consumers’ perception of its products.
A BBB National Programs, Inc. investigative unit tells FTC that Dose of Nature failed to respond to its request to support its CBD oil claims; Utah direct sellers Young Living and doTerra agree to pull or modify drug claims for their essential oil products; HempWorx relabels topical as cosmetic.
Consumer health product firms say the coronavirus will have an impact on their results, but it’s too early to estimate the costs. US FDA also hedges its predictions, saying the outbreak could lead to interruptions in country’s drug and medical device supplies. China's health commission has issued six guidelines for diagnosis and treatment, but no conventional antiviral treatment is approved and it's emphasizing traditional Chinese medicines.